Literature DB >> 27082295

Prolyl-4-Hydroxylases Inhibitor Stabilizes HIF-1α and Increases Mitophagy to Reduce Cell Death After Experimental Retinal Detachment.

Haiyang Liu1, Hong Zhu2, Tong Li2, Pengfei Zhang2, Ning Wang2, Xiaodong Sun3.   

Abstract

PURPOSE: This study investigated the neuroprotective effect against photoreceptor cell death using prolyl-4-hydroxylases inhibitor (PHI), an HIF-1α stabilizer, in experimental retinal detachment (RD).
METHODS: RD was created in Brown Norway rats by subretinal injection of 1% sodium hyaluronate. FG-4592 (a PHI, 25 mg/kg) or a vehicle was administered every 2 days with retro-orbital injection. Photoreceptor death was evaluated by TdT-dUTP terminal nick-end labeling (TUNEL) assay 3 days after RD and by the thickness of the outer nuclear layer 7 days after RD. The mitophagy-related markers Hypoxia Inducible Factor 1α (HIF-1α), BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3), autophagy-related gene 5 (Atg5), microtubule-associated protein 1 light chain 3 beta (LC3B), and FUN14 domain containing 1 (FUNDC1) were detected by Western blot and immunofluorescence. Transmission electron microscopy was used to observe ultramicro-morphological changes. Mitochondrial damage was evaluated by the measurement of reactive oxygen species (ROS) by in situ ROS detection with dihydroethidium.
RESULTS: The accumulation of HIF-1α and BNIP3 significantly increased after PHI treatment (P < 0.05), the pattern of Atg5 and LC3 changed, and FUNDC1 and LC3 were colocated. More autophagic vacuoles engulfing mitochondria were observed in transmission electron microscopy sections after PHI treatment when compared with the control. ROS significantly decreased in the PHI-treatment group (P < 0.05). This resulted in reduced TUNEL-positive photoreceptors 3 days after RD and an increased thickness of the outer nuclear layer 7 days after RD (P < 0.05).
CONCLUSIONS: HIF-1α stabilization as a result of PHI treatment, along with the enhancement of mitophagy, could provide protection against photoreceptor injury following RD, which might be mediated by excessive ROS generation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27082295     DOI: 10.1167/iovs.15-18066

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.

Authors:  Tong Li; Shiqi Yang; Xiangjun She; Quan Yan; Pengfei Zhang; Hong Zhu; Fenghua Wang; Xueting Luo; Xiaodong Sun
Journal:  Br J Pharmacol       Date:  2019-01-30       Impact factor: 8.739

2.  Hypoxia-Inducible Factor-1α in Rods Is Neuroprotective Following Retinal Detachment.

Authors:  Bing X Ross; Lin Jia; Dejuan Kong; Tiantian Wang; Jingyu Yao; Heather M Hager; Steven F Abcouwer; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

3.  Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin.

Authors:  Yasir J Sepah; Quan Dong Nguyen; Yusuke Yamaguchi; Tetsuro Otsuka; Yoshikatsu Majikawa; Michael Reusch; Tadao Akizawa
Journal:  Kidney Int Rep       Date:  2022-01-19

4.  Detrimental effect of Hypoxia-inducible factor-1α-induced autophagy on multiterritory perforator flap survival in rats.

Authors:  Long Wang; Zhicheng Jin; Jieke Wang; Shao Chen; Li Dai; Dingsheng Lin; Lingfeng Wu; Weiyang Gao
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

Review 5.  Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases.

Authors:  Mengqiu Miao; Mengqiu Wu; Yuting Li; Lingge Zhang; Qianqian Jin; Jiaojiao Fan; Xinyue Xu; Ran Gu; Haiping Hao; Aihua Zhang; Zhanjun Jia
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

6.  ROS-mediated BNIP3-dependent mitophagy promotes coelomocyte survival in Apostichopus japonicus in response to Vibrio splendidus infection.

Authors:  Lian-Lian Sun; Yi-Na Shao; Mei-Xiang You; Cheng-Hua Li
Journal:  Zool Res       Date:  2022-03-18

Review 7.  Roxadustat: Not just for anemia.

Authors:  Xiaoyu Zhu; Lili Jiang; Xuejiao Wei; Mengtuan Long; Yujun Du
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

8.  B355252, A Novel Small Molecule, Confers Neuroprotection Against Cobalt Chloride Toxicity In Mouse Hippocampal Cells Through Altering Mitochondrial Dynamics And Limiting Autophagy Induction.

Authors:  Uchechukwu Chimeh; Mary Ann Zimmerman; Nailya Gilyazova; P Andy Li
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

9.  Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.

Authors:  Wei-Ting Chang; Yi-Ching Lo; Zi-Han Gao; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

10.  Selective Histone Deacetylase 6 Inhibitors Restore Cone Photoreceptor Vision or Outer Segment Morphology in Zebrafish and Mouse Models of Retinal Blindness.

Authors:  Husvinee Sundaramurthi; Sarah L Roche; Guinevere L Grice; Ailis Moran; Eugene T Dillion; Giuseppe Campiani; James A Nathan; Breandán N Kennedy
Journal:  Front Cell Dev Biol       Date:  2020-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.